Reverse Transcriptase Inhibitors in HIV/AIDS Therapy by Gail SkowronReverse Transcriptase Inhibitors in HIV/AIDS Therapy by Gail Skowron

Reverse Transcriptase Inhibitors in HIV/AIDS Therapy

byGail SkowronEditorRichard Ogden

Paperback | November 19, 2010

Pricing and Purchase Info

$389.65 online 
$440.50 list price save 11%
Earn 1,948 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


A magisterial survey of all aspects of the reverse transcriptase inhibitors (RTIs) used to treat HIV/AIDS, including drug discovery, pharmacology, development of drug resistance, toxicity, and prevention of mother-to-child transmission of HIV/AIDS. The authors synthesize our current understanding of the role of reverse transcriptase in the viral life cycle, describe the discovery and development of eight nucleoside and nucleotide analogs that represent milestones in treatment history, and thoroughly discuss the question of toxicity and resistance to this class of drugs. They also address three non-nucleoside RTIs and their pharmacokinetics and comparative clinical efficacy, new RTIs currently under development, and the impact of approved agents on treatment, in general, and on vertical transmission in the developing world.
Title:Reverse Transcriptase Inhibitors in HIV/AIDS TherapyFormat:PaperbackDimensions:528 pages, 22.9 × 15.2 × 0.17 inPublished:November 19, 2010Publisher:Springer-Verlag/Sci-Tech/TradeLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:1617376957

ISBN - 13:9781617376955

Look for similar items by category:


Table of Contents

Structural Studies on HIV Reverse Transcriptase Related to Drug Discovery David K. Stammers and Jingshan Ren Zidovudine, Lamivudine, and Abacavir Monica Carten and Harold Kessler Stavudine, Didanosine, and Zalcitabine Gail Skowron, Sapna Chowdhry, and Michael R. Stevens Emtricitabine Gail Skowron, Jeffrey Bratberg, and Rudi Pauwels Nucleotide Analogs Craig J. Hoesley Resistance to Nucleoside and Nucleotide Reverse Transcriptase Inhibitors Nancy Shulman and Mark Winters Pharmacokinetics of Reverse Transcriptase Inhibitors Patrick Hoggard, Stephen Kewn, Saye Khoo and David Back Peripheral Neuropathy Associated With Nucleoside Reverse Transcriptase Inhibitor Therapy Bruce A. Cohen and Russell Bartt Mitochondrial Dysfunction and Nucleoside Reverse Transcriptase Inhibitor Therapy: A Pathophysiological Perspective William Lewis Mitochondrial Toxicity and Lipodystrophy Grace McComsey Nevirapine David Asmuth and Richard Pollard Efavirenz Graeme J. Moyle and Brian Conway Delavirdine Brian Conway Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors F. Ramzi Asfour and Richard Haubrich Vertical Transmission of HIV and Therapeutic Interventions Susan Cu-Uvin, Arlene Bardeguez, and Carla Chibwesha New Reverse Transcriptase Inhibitors in Development Rudi Pauwels Antiretroviral Drugs for Millions Allan Ronald, Elly Katabira, and Merle Sande Postscript Richard Ogden and Gail Skowron Index

Editorial Reviews

From the reviews:"This book will appeal to medical students needing a detailed review of area . . It is most suitable for libraries . . The individual chapters are authoritative and comprehensive . . a source for in-depth and specific information." (Mark Harris, Microbiology Today, November, 2006)